✽ Biotech firm Malin has raised up to €330 million in one of Europe’s biggest life science IPOs.
The Irish company, which was set up by a number of former Elan executives, beat its target range of €275 to €325 million. The company will be admitted to Ireland’s ESM (Enterprise Securities Market) on Wednesday.
Dr Adrian Howd, Malin’s chief executive, said the company was “very gratified at the level of investor support...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team